Charting New Territories in Kinase Drug Discovery


     Confluence was founded in 2010 by a team of industry-experienced drug hunters with a track record of success in driving programs from inception through clinical development.  Confluence has built a team of researchers and advisors to include a number of outstanding scientists and business personnel dedicated to moving drugs to the market. Our goal is to build a sustainable drug discovery and early development company that creates new assets from the KINect™ Technology Platform.